Achievements and News

January 2018
Dr. Dinesh Khanna is a guest speaker on ReachMD and discusses managing patients with SS-ILD, Interstitial Lung Disease in Scleroderma: Early Recognition and Emerging Therapeutic Options.
 

2017

December 2017

U-M Scleroderma Program Manager, Jodie Fisher, Hope Award Finalist

Jody Fisher, Program Manager of the Scleroderma Program, was nominated for an Evan Newport HOPE Award and ended up a HOPE Finalist for Adult Services, out of over 100 nominations.
 
 
 
 
 
 
 


October 2017
Sheri Hicks, a patient of the U-M Scleroderma Program talks about her experience with the Scleroderma Program and Program Director, Dr. Dinesh Khanna, in USA Today, "Journey of hope: Autoimmune disease patient raises funds, promotes education". View pictures from the event at right.

View the recent Pulmonary Hypertension & Scleroderma Brochure written and developed by Dr. Khanna for the Pulmonary Hypertension Association.

Dr. Khanna featured in Michigan Medicine Headlines, Service Spotlight: Doc's Commitment to Patient 'Priceless'


September 2017
Doctors, professors, and professionals from the ASSET study met from around the world at the University of Michigan to discuss the progress of the study, as well as the successes of its collaboration.

Doctors, professors, and professionals from the ASSET study meet at U-M


August 2017
Dr. Khanna serves as a member of the Teaching Faculty at the 18th Singapore Society of Rheumatology-Malaysian Society of Rheumatology Workshops in Rheumatology 2017. View the 18th Singapore Society of Rheumatology-Malaysian Society of Rheumatology Workshops in Rheumatology 2017 website to learn more about the event.

18th Singapore Society of Rheumatology-Malaysian Society of Rheumatology Workshops in Rheumatology

18th Singapore Society of Rheumatology-Malaysian Society of Rheumatology Workshops in Rheumatology


July 2017
The STAR Trial of Habeo Cell Therapy in Patients with Scleroderma announces details and results from its study. This form of cell therapy appears to benefit patients with the diffuse form of the disease, representing a valuable new piece of information for the field. Learn more about the STAR trial and the announcement from Cytori.

The 2017 Scleroderma Foundation National Patient Education Conference was held July 21 to July 23 in Chandler, Arizona.


June 2017
NIAMS (National Institute of Arthritis and Musculoskeletal and Skin Diseases) hosted a Twitter chat on June 29, with experts from across the nation participating. Read more.

On June 4, 2017, the Scleroderma Foundation Michigan Chapter hosted its annual Stampede Scleroderma event: a 5k at the Detroit Zoo to raise money for scleroderma research, support, and education.


February 2017
Dr. Khanna and colleagues publish "Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis" in the Journal of Scleroderma and Related Disorders.

2016

November 2016
The University of Michigan Division of Rheumatology releases the Autumn 2016 edition of its newsletter, RheUMinations. This edition features information on the Scleroderma Program, including the RESCUE study, Dr. Tsou's New Investigator Award, and a number of presentations to be held during the 2016 ACR National Meeting.


August 2016
Professor Khanna attends the First Scleroderma meeting arranged by the Indian Rheumatology Association in Bangalore, India.

Indian Rheumatology Association, 2016 Advanced Rheumatology Course


July 2016
"Hand Impairment in Systemic Sclerosis: Various Manifestations and Currently Available Treatment" article was published by the UM Scleroderma Program and Occupational Therapy Division in the Department of Physical Medicine and Rehabilitation.

UM Scleroderma team leads a pilot study of pirfenidone in scleroderma-associated lung fibrosis. Read more


June 2016
The Scleroderma Program hosted its Scleroderma Update event, where patients were able to talk to doctors and coordinators about the latest research. View pictures.

Dr. Khanna is honored in the Spring 2016 edition of Medicine at Michigan.

UM Scleroderma Program publishes pilot study of acupressure in Raynaud’s phenomenon. Read more.

Dr. Khanna publishes "Emerging strategies for treatment of systemic sclerosis."

On Sunday, June 5, 2016, UM Scleroderma Research team members participated in the 2016 Stampede Scleroderma Walk at the Detroit Zoo. As part of the event, a 10K run, 5K run, 1 mile run, and a Zoo walk were all offered to participants. There was a tremendous turnout for the event, and best of all, we missed the rain by minutes!

2016 Stampede Scleroderma Walk at the Detroit Zoo


May 2016
UM Scleroderma Program Director is the lead author for 2 large clinical trials in scleroderma. Read more. Learn more about the "Effect of Macitentan on the Development of New Ischemic Digital Ulcers in Patients With Systemic Sclerosis".

Dr. Khanna publishes findings of the FaSScinate study in The Lancet. Learn more about the "Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial".


February 2016
Dr. Tsou receives the Marta Marx Fund for the Eradication of Scleroderma.

Dr. Khanna and the UM Scleroderma Program led the development of the "American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis", which has the potential to revolutionize the conduct of clinical trials in systemic sclerosis. Supplemental material.

Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis

2015

December 2015
Dr. Dinesh Khanna receives the Henry Kunkel Young Investigator Award from the American College of Rheumatology, which is part of the ACR Awards of Distinction, a series of awards given out annually to recognize its members’ contributions to the field of rheumatology. The Henry Kunkel Young Investigator Award is awarded to a young physician scientist, age 45 or younger by October 1 of the year in which they are nominated, who has made outstanding and promising independent contributions to basic or clinical research in the field of rheumatology.


September 2015
Dr. Khanna speaks on Scleroderma at the Harvard Rheumatology CME Program.

The APLAR 2015 meeting, organized by the American College of Rheumatology, was held in Chennai, India.

Dr. Khanna at APLAR 2015 meeting


August 2015
The Prospective Registry of Systemic Sclerosis (PRESS) is featured in Scleroderma Voice magazine. The PRESS Registry recently received the Scleroderma Foundation Collaborative Research (SCORE) grant.


June 2015
"FDA Grants Breakthrough Therapy Designation for Actemra in Systemic Sclerosis".


April 2015
Dr. Khanna presents at the 33rd Annual Carl M. Pearson Memorial Symposium.


January 2015
U-M researchers, Dinesh Khanna, MD, MSc and Cathie Spino, ScD, receive $7M to study scleroderma treatment.

"Cytori and Leading Expert Discuss Importance of ‘STAR’ Trial and Treatment for Scleroderma Patients".

2014

December 2014
Meeting of the The Prospective Registry of Systemic Sclerosis (PRESS) at the University of Michigan. The project spans 11 centers, and met to standardize and align research efforts in the various fields at each center.


November 2014
Medical School honors 70 faculty and staff at Dean’s Awards, research league events.

The University of Michigan Medical School recently celebrated outstanding faculty and staff during a pair of awards ceremonies in the Gilbert S. Omenn Atrium of the A. Alfred Taubman Biomedical Science Research Building.

Dr. Dinesh Khanna was honored with the Dean’s Awards for his service to the school’s tripartite mission. He received this award for being an outstanding educator, investigator, and clinician.


September 2014

"Development of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) Gastrointestinal Symptom Scales", co-written by Dr. Dinesh Khanna, is published in The American Journal of Gastroenterology.


May 2014
Dr. Dinesh Khanna featured in the May 2014 IRA e-bulletin.


April 16, 2014
"U-M, MSU Researchers Find 'Off' Switch for Scleroderma". Discovery brings researchers one step closer to unraveling devastating disease.


April 3, 2014
"Flipping the Switch on Scleroderma". Colleagues from Michigan State University and the University of Michigan have identified the core signaling pathway that activates the disease and the chemical compounds that can turn it off.

"Targeting the Myofibroblast Genetic Switch: Inhibitors of MRTF/SRF-regulated Gene Transcription Prevent Fibrosis in a Murine Model of Skin Injury", The Journal of Pharmacology and Experimental Therapeutics.


February 6-8, 2014
Dr. Khanna speaks at the 3rd Systemic Sclerosis World Congress in Rome, Italy. He also served on the Steering Committee.

3rd Systemic Sclerosis World Congress

2013

December
"Recommendations for Screening and Detection of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension".

October
New scleroderma classification criteria published by ACE/ EULAR. Dr. Khanna participated and played a pivotal role in developing this criteria. Learn more.

August
Dr Khanna invited to Hamilton, New Zealand to present at their annual rheumatology meeting. Dr. Khanna discussed the latest evidence in the management of pulmonary arterial hypertension and other topics on diagnosis and management of scleroderma.

June
Dr. Khanna presented the first recommendations for screening and diagnosis of connective tissue disease-associated pulmonary arterial hypertension at the annual EULAR meeting in Madrid, Spain.
 

 

Learn More:

Return to Home